{
    "clinical_study": {
        "@rank": "95982", 
        "brief_summary": {
            "textblock": "To compare the time to progression of CMV retinitis between oral ganciclovir and IV\n      ganciclovir during 20 weeks of maintenance treatment. To compare the safety and tolerance of\n      oral ganciclovir with IV ganciclovir therapy during 20 weeks of maintenance treatment. To\n      describe the safety and tolerance of oral ganciclovir treatment when given concurrently with\n      anti-retroviral treatment, e.g. zidovudine or ddI. To describe the survival of people with\n      AIDS and CMV retinitis."
        }, 
        "brief_title": "A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS", 
        "condition": [
            "Cytomegalovirus Retinitis", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Retinitis", 
                "Cytomegalovirus Retinitis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Approximately 150 subjects with AIDS and newly diagnosed CMV retinitis will be enrolled in\n      the study to achieve 120 randomized subjects. Eligible subjects will have CMV retinitis\n      which has been diagnosed within one month of study entry by an ophthalmologist using\n      indirect ophthalmoscopy. Subjects will be accrued by recruitment or referral. Anyone who\n      volunteers for the study, meets the eligibility criteria, and signs an informed consent will\n      be eligible for entry."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have the following:\n\n          -  Confirmation of HIV infection by HIV-antibody testing, p24 antigen assay, or culture\n             of HIV, or have diagnosis of AIDS by CDC criteria.\n\n          -  CMV retinitis diagnosed within one month of study entry.\n\n          -  Understand the nature of the study, agree to its provisions, and sign the informed\n             consent approved by the appropriate institutional review board and Syntex.\n\n        Exclusion Criteria\n\n        Concurrent Medication:\n\n        The following are excluded:\n\n          -  Antimetabolites. Alkylating agents. Selected nucleoside analogs. Selected Cytokines.\n\n        Patients with the following are excluded:\n\n          -  Persistent diarrhea, nausea, or abdominal pain or other clinically significant GI\n             symptoms or uncontrolled gastrointestinal disease. Diarrhea is defined as 3 or more\n             unformed stools per day.\n\n          -  Have ocular media opacities (corneal, lenticular, or vitreal) preventing\n             ophthalmologic retinal assessment and photography.\n\n          -  Have ocular conditions requiring immediate surgical correction (e.g. retinal tear or\n             detachment).\n\n          -  Require continuation of concomitant medications precluded by this protocol, e.g.,\n             antimetabolites, alkylating agents, selected nucleoside analogs, and selected\n             cytokines and other medications listed in the protocol.\n\n          -  History of hypersensitivity to acyclovir or ganciclovir.\n\n          -  Dementia, decreased mentation or other encephalopathic signs and symptoms which would\n             interfere with the ability of the subject to give informed consent or comply with the\n             protocol.\n\n        Prior Medication:\n\n        The following are excluded:\n\n        - Previous use of anti-cytomegalovirus drug (e.g., ganciclovir, foscarnet, FIAC, or CMV\n        hyperimmune globulin) within one month of study entry."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "150", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002257", 
            "org_study_id": "059B", 
            "secondary_id": "ICM 1653"
        }, 
        "intervention": {
            "intervention_name": "Ganciclovir", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Ganciclovir"
        }, 
        "keyword": [
            "Retinitis", 
            "Ganciclovir", 
            "Cytomegalovirus Infections", 
            "Acquired Immunodeficiency Syndrome"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Berkeley", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94704"
                    }, 
                    "name": "East Bay AIDS Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94114"
                    }, 
                    "name": "Davies Med Ctr / c/o HIV Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94118"
                    }, 
                    "name": "Dr David Busch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20007"
                    }, 
                    "name": "Georgetown Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33125"
                    }, 
                    "name": "Miami Veterans Administration Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33125"
                    }, 
                    "name": "Med Service"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Rush Presbyterian - Saint Luke's Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Beth Israel Deaconess Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "New York Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Cornell Univ Med College"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "Buckley Braffman Stern Med Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Galveston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77550"
                    }, 
                    "name": "Univ TX Galveston Med Branch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "Canada", 
                        "state": "British Columbia"
                    }, 
                    "name": "Saint Paul's Hosp"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "official_title": "A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002257"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 1992"
    }, 
    "geocoordinates": {
        "Beth Israel Deaconess Med Ctr": "42.358 -71.06", 
        "Buckley Braffman Stern Med Associates": "39.952 -75.164", 
        "Cornell Univ Med College": "40.714 -74.006", 
        "Davies Med Ctr / c/o HIV Institute": "37.775 -122.419", 
        "Dr David Busch": "37.775 -122.419", 
        "East Bay AIDS Ctr": "37.872 -122.273", 
        "Georgetown Univ Med Ctr": "38.895 -77.036", 
        "Med Service": "25.789 -80.226", 
        "Miami Veterans Administration Med Ctr": "25.789 -80.226", 
        "New York Univ Med Ctr": "40.714 -74.006", 
        "Rush Presbyterian - Saint Luke's Med Ctr": "41.878 -87.63", 
        "Saint Paul's Hosp": "49.261 -123.114", 
        "Univ TX Galveston Med Branch": "29.301 -94.798"
    }
}